Affiliation:
1. Department of Medical Lab Technology, College of Health and Medical Technology, Southern Technical University , Basra , Iraq
2. Advisory Clinic for Chest Diseases and Respiratory , Basra , Iraq
Abstract
Abstract
Drug-resistant Mycobacterium tuberculosis (DR-MTB) is a major health threat to human beings. This study aimed to evaluate the prevalence and drug resistance profile of MTB. Data were collected from 2,296 newly diagnosed, and 246 retreated tuberculosis (TB) patients who attended the Advisory Clinic for Chest Diseases and Respiratory in Basra province from January 2016 to December 2020. Both new diagnostic and retreated TB cases showed that DR-MTB cases were significantly higher at age 15–34 years, pulmonary TB, and urban residents but with no significant difference regarding gender. The drugs resistance was significantly higher among the retreated cases compared with the new diagnostic patients (20.3% vs. 2.4%, p < 0.0001), with the percentage of the resistance to first-line drugs in primary and secondary cases including isoniazid (1% and 17.1%), rifampicin (0.78% and 15.8%), ethambutol (0.56% and 8.5%), streptomycin (1.3% and 9.75%). Notice that the most common drug resistance was against streptomycin with 1.3% in new patients and against isoniazid (17.1%) in retreated patients. The rate of total drug-resistant TB, multi-drug resistant TB, mono-drug resistant TB, and rifampicin-resistant TB among new tuberculosis cases increased in this period from 2.2 to 6.7%, 0.17 to 1.6%, 0.85 to 4%, and 0.17 to 4%, with a percentage change of 204.54, 841.17, 370.58, 22.5%, respectively. The rates of poly drug-resistant TB and ethambutol-resistant-TB dropped in this period by 15.96%, and 0.7%, with a decrease from 1.19 to 1% and from 1 to 0.3%, respectively. Similarly, the increase of drug-resistant TB among secondary cases has also occurred. In conclusion, the temporal trend showed an increase in the rate of drug resistance of M. tuberculosis since 2016, with a predominant multi-drug-resistant TB and isoniazid-resistant TB.
Publisher
Polish Society of Microbiologists
Subject
Microbiology (medical),Applied Microbiology and Biotechnology,General Medicine,Microbiology
Reference45 articles.
1. Ahmed ST. Molecular investigation and genotyping of pulmonary Mycobacterium tuberculosis strains in Iraq [PhD Thesis]. Baghdad (Iraq): University of Baghdad, College of Science for Women; 2018.
2. Al-Khafaji J. Characterization of Mycobacterium tuberculosis and predisposition factors association with tuberculosis among risk population in Baghdad city. JUBPAS. 2014;22(9):2547–2558.
3. Almeida D, Rodrigues C, Udwadia ZF, Lalvani A, Gothi GD, Mehta P, Mehta A. Incidence of multidrug-resistant tuberculosis in urban and rural India and implications for prevention. Clin Infect Dis. 2003;36(12):e152–e154. https://doi.org/10.1086/374931
4. Al-Rubayai DS. Molecular detection of specific gene mutations associated with isoniazid or rifampicin resistance among category II pulmonary tuberculosis using DNA microarray [PhD Thesis]. Baghdad (Iraq): Al-Nahrain University, College of Medicine; 2011.
5. Bedewi SG. Assessment of the resistance of the Mycobacterium tuberculosis to antibiotics and investigation the associated bacteria in patients [Master Thesis]. Baghdad (Iraq): University of Baghdad, College of Science for Women; 2011.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献